MELAS

Disease Overview

MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) is a rare, progressive genetic disorder characterized by mitochondrial dysfunction. It primarily affects the nervous system and muscles, causing significant neurological and metabolic complications. The disorder is part of a group of mitochondrial diseases that impair the body's ability to generate energy at the cellular level.

Disease Category

Mitochondrial Genetic Disorder Neurometabolic Disorder

Synonyms

MELAS syndrome
Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes
Mitochondrial Encephalomyopathy with Lactic Acidosis

Signs & Symptoms

Stroke-like episodes (typically before age 40)
Seizures
Recurrent headaches or migraines
Progressive muscle weakness
Exercise intolerance
Hearing loss
Vision problems
Diabetes mellitus
Cardiac issues (cardiomyopathy)
Lactic acidosis
Developmental delays
Cognitive impairment
Gastrointestinal problems
Short stature

Causes

Genetic mutations in mitochondrial DNA (mtDNA)
Primary mutation in the MT-TL1 gene (most common)
Other possible mutations in MT-ND1, MT-ND5, and MT-TH genes
Inherited through maternal transmission
Affects mitochondrial protein synthesis and energy production

Affected Populations

Rare disorder affecting approximately 1 in 4,000 to 1 in 8,000 individuals
Can occur at any age, but typically begins in childhood or early adulthood
No significant gender predilection
Affects all ethnic groups

Disorders with Similar Symptoms

Leigh syndrome
MERRF syndrome
Mitochondrial neurogastrointestinal encephalopathy
Other mitochondrial disorders
Epilepsy
Multiple sclerosis
Muscular dystrophy

Diagnosis

Comprehensive clinical evaluation
Detailed family medical history
Muscle biopsy (revealing "ragged red fibers")
Neuroimaging (MRI, CT scans)
Genetic testing for mtDNA mutations
Blood and cerebrospinal fluid lactate levels
Electroencephalogram (EEG)
Electromyography (EMG)

Standard Therapies

No definitive cure
Symptomatic and supportive treatment
Anticonvulsant medications
Physical therapy
Nutritional supplements
Coenzyme Q10
L-carnitine
Vitamin B complex
Management of associated conditions
Genetic counseling

Clinical Trials and Studies

Ongoing research at major medical centers
Experimental therapies targeting mitochondrial function
Gene therapy investigations
Clinical trials listed on ClinicalTrials.gov
Research focused on mitochondrial disease mechanisms

References

National Institutes of Health (NIH)
Genetics Home Reference
National Organization for Rare Disorders (NORD)
Mitochondrial Medicine Society
Peer-reviewed medical journals

Programs & Resources

United Mitochondrial Disease Foundation
MitoAction
Rare Diseases Clinical Research Network
Genetic counseling services
Online support groups and forums

Complete Report

MELAS is a complex mitochondrial disorder with significant neurological and metabolic implications. While current treatments focus on managing symptoms, ongoing research offers hope for more targeted therapies in the future. Comprehensive care requires a multidisciplinary approach involving neurologists, geneticists, and other specialists.